The United States is the global leader in ensuring patients have timely and sustained access to the newest, innovative medicines. As policymakers in Washington D.C. consider various drug pricing reforms, one idea under discussion is the adoption of a national health technology assessment entity.
COVID-19 has interrupted our global healthcare systems, creating issues with patient access, new medicines development and global advocacy initiatives, as more than half of the world's population was under some form of lockdown in 2020. It also illuminated racial and ethnic healthcare disparities that have run rampant for far too long. In the face of these profound challenges, many advocates and healthcare providers have a new understanding of the issues facing their communities. This session will feature global experts as they discuss the insights they’ve gained throughout the pandemic, and how they’ve given a voice to those who are often voiceless.
Join us for an interactive conversation with Mark Bertolini, national healthcare thought leader and former chairman and chief executive officer of Aetna Inc. A pioneer in the industry, he led the company’s transition from a traditional health insurance company to a consumer-oriented healthcare company focused on delivering holistic, integrated care in local communities. After hearing from Mark, our Working Group leaders will join the dialogue to share key insights from their group discussions, including how each are reimagining healthcare.
Living a full life after a diagnosis, or managing a chronic disease, is a relatively new focus in global health and healthcare. To celebrate National Cancer Survivor Month in the United States (U.S.) in June, we will delve into the topic of living with a disease and explore what this means for individuals around the world.
More than a year into a global pandemic, the need for awareness, connection and resources to support wellbeing and mental health are more important than ever. In recognition of Mental Health Awareness Month in the U.S. in May, join us to hear Teri Brister, national director, research & quality assurance at NAMI (National Association on Mental Illness), discuss how to navigate the U.S. healthcare system to receive mental health support.
So far in 2021, the COVID Advocacy Exchange has brought the global advocacy community together to not only hear from each other, but to prioritize and begin to tackle global health issues. Discussions in the first quarter of the year have focused on "Patient Insights Influencing Action," "Harnessing Our United Strength to Create Meaningful Change," and "Outlining Our Paths to Impact and Change."
As our companies operate against the backdrop of an unfolding global pandemic and a massive societal change, a new reality is emerging. Disruption that seemed like a sprint is proving to be a marathon. The “new normal” is never returning.
As individuals experience these topics in different ways, our first Working Group session was focused on understanding meaning to establish a common baseline from which to grow. As we continue to build a strong foundation for success, our second Working Group session on March 11 will identify those...